Alabama
Birmingham; Birmingham Psychiatry Pharmaceutical Studies, Incorporated
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Arkansas
Little Rock; K&S Professional Research Services, LLC
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Little Rock; Study Site
Clinical Study of Schizophrenia.
California
Cerritos; Clinical Pharmacological Studies
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Cerritos; Comprehensive NeuroScience, Inc. Cerritos
Cerritos, CA - Schizophrenia
Costa Mesa; ATP Clinical Research
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Costa Mesa; ATP Clinical Research
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Culver; California Clinical Trials Medical Group, Inc.
Do you have schizophrenia or schizoaffective disorder?
Garden Grove; Collaborative Neuroscience Network
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Garden Grove; Study Site
Clinical Study of Schizophrenia.
Glendale; CNS Healthcare
Schizophrenia and Schizoaffective Disorders Study
Glendale; California Clinical Trials Medical Group, Inc.
An inpatient study comparing different types of the same study medication administered to subjects with schisophrenia, schizoaffective disorder, or schisophreniform disorder.
Granada Hills; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
La Mesa; Study Site
Clinical Study of Schizophrenia.
Los Angeles; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Oceanside; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Oceanside; Study Site
Clinical Study of Schizophrenia.
Orange; UC Irvine Medical Center
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Orange; University of California - Irvine Medical Center
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Palo Alto; Stanford University School of Medicine
The study is looking at the metabolic side effects of the new antipsychotic medications. Participants should be stable on one of the following medications: olanzapine (zyprexa), ziprasidone (geodon), risperidone (risperdal) or aripiprazole (abilify). Patient's medications won't be changed. The study involves 3 visits at the Palo Alto VA and Stanford Hospital.
Pico Rivera; California Neuropsychopharmacology Clinic
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Rosemead; Study Site
Clinical Study of Schizophrenia.
Sacramento; Sierra Vista Hospital
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
San Diego; CNRI - San Diego
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
San Diego; Study Site
Clinical Study of Schizophrenia.
Sherman Oaks; Schuster Medical Research Institute
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Sherman Oaks; Schuster Medical Research Institute
VOLUNTEERS WANTED FOR A SCHIZOPHRENIA CLINICAL TRIAL
Stanford; Stanford University School of Medicine
Treatment of Schizoaffective Disorder Using Mifepristone
Stanford; Stanford University School of Medicine
First Episode Psychosis Study (CAFÉ)
Stanford; Stanford University School of Medicine
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Connecticut
Hartford; Burlingame Center for Psychiatric Research and Education
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
New Britain; The Hospital of Central Connecticut
A Research Study of Cognitive Deficits in Schizophrenia
New Britain; The Hospital of Central Connecticut
Are you caring for someone with Schizophrenia?
New Britain; The Hospital of Central Connecticut
Do you take one of these medications for SCHIZOPHRENIA: Zyprexa, Risperdal, Risperdal Consta, Invega, Seroquel or Abilify?
Florida
Gainesville; University of Florida
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Hialeah; Berma Research Group
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Maitland; Florida Clinical Research Center (formerly Core Research)
Diagnosed with Schizophrenia?
North Miami; Study Site
Clinical Study of Schizophrenia.
Orlando; CNS Healthcare - Orlando
Schizophrenia Research Study (and schizoaffective disorders)
Winter Park; Study Site
Clinical Study of Schizophrenia.
Georgia
Atlanta; Comprehensive NeuroScience, Inc. Atlanta
Atlanta, GA - Schizophrenia
Atlanta; Comprehensive NeuroScience, Inc. Atlanta
Atlanta, GA - Insomnia
Illinois
Chicago; Uptown Research Institute, LLC
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Chicago; Rush University Medical Center
Medication study to improve cognitive functioning (such as problems with learning, remembering, poor memory, difficulty concentrating and problems putting thoughts and emotions into words
Granite City; Study Site
Clinical Study of Schizophrenia.
Hoffman Estates; Alexian Brothers
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Hoffman Estates; Comprehensive Neuroscience, Inc.
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Hoffman Estates; Comprehensive NeuroScience, Inc. Hoffman Estates
Hoffman Estates, IL - Schizophrenia
Hoffmann Estates; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Oakbrook Terrace; Midwest Center for Neurobehavioral Medicine
Clinical study for Schizophrenia
Kansas
Wichita; Clinical Research Institute - Kansas
Comparison of Antipsychotics for Metabolic Problems (CAMP) in the Treatment of People with Schizophrenia or Schizoaffective Disorder
Louisiana
Lake Charles; Lake Charles Clinical Trials
Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients
Lake Charles; Lake Charles Clinical Trials
Study Comparing Bifeprunox to Risperidone in the Treatment of Outpatients with Schizophrenia with Weight as the Primary Endpoint
Lake Charles; Lake Charles Clinical Trials
Switch Study of Existing Atypical Antipsychotics to Bifeprunox
Shreveport; J. Gary Booker, MD
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Shreveport; Psychopharmacology Research Clinic LSUHSC-Shreveport
CAMP Schizophrenia Study
Maryland
Baltimore; Sheppard Pratt Health System
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Baltimore; Sheppard Pratt Health System
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Glen Burnie; Clinical Insights, Inc
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Glen Burnie; Study Site
Clinical Study of Schizophrenia.
Massachusetts
Boston; Massachusetts General Hospital (MGH)
A Psychological Study of Fear Conditioning and Extinction in Schizophrenia
Boston; Schepens Eye Research Institute
Effects of eszopiclone on Sleep and learning in chronic, medicated schizophrenia patients
Boston; Massachusetts General Hospital (MGH)
MK-0777 for the Treatment of Cognitive Impairments for Patients with Schizophrenia
Boston; Boston University Psychiatry Associates
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Boston; Study Site
Clinical Study of Schizophrenia.
Brookline; Arbor-HRI
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Haverhill; ActivMed Practices & Research, Inc.
Schizophrenia
Taunton; CCBC
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Michigan
Bingham Farms; Neuroscience Research Associates
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
West Bloomfield; Neuroscience Research Associates
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Minnesota
Minneapolis; Ambulatory Research Center (ARC)
Schizophrenia and Schizoaffective Disorders, Minneapolis, MN
Minneapolis; University of Minnesota, Department of Psychiatry
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Mississippi
Flowood; Precise Research Centers
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Missouri
St. Louis; Millennium Psychiatric Associates, LLC
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
New Jersey
Cherry Hill; Center For Emotional Fitness
Schizophrenia Can Decrease Your Memory and Your Thinking Ability
Clementon; CRI Worldwide
A Single-Arm Evaluation of the Safety of XXXX in Subjects with Schizophrenia or Schizoaffective Disorder with Hepatic Disease.
Clementon; CRI Worldwide
A Blinded-Initiation Study of Medication Satisfaction in Subjects with Schizophrenia Treated with XXXX after Suboptimal Response to Oral Risperidone
Clementon; CRI Worldwide
A Single Dose, Open-Label, Randomized, 2-Period, Parallel Group Study to Asses the Pharmacokinetics, Safety, and Tolerability of XXXX 3-month formulation in Subjects with Schizophrenia.
Clementon; CRI Worldwide
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study with 3 Oral Dose Groups of XXXXXXX during 12 weeks Treatment of Cognitive Deficits in Patients with Schizophrenia.
Clementon; CRI Worldwide
A Phase 3 Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of Three Doses of XXXX in Acutely Psychotic Patients with Schizophrenia.
Clementon; CRI Worldwide
An Open-Label, Long-Term, Multiple-Dose, Safety and Tolerability, Pharmacokinetic Study of XXXX in the Treatment of Subjects with Schizophrenia.
Clementon; CRI Worldwide
A Randomized, Double-Blind, Placebo-Controlled, Risperdone-Referenced, Parallel-Group, Adaptive-Design Study of the Efficacy, Safety, and Tolerability of XXXX in Subjects with Acute Exacerbations of Schizphrenia.
Clementon; CRI Worldwide
A Phase 1b Inpatient, Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Safety and Efficacy of Two Fixed Doses of XXXXXX in Adjunctive Treatment of Cognitive Deficits in Schizophrenia.
Clementon; CRI Worldwide
A Phase 3 Randomized, Placebo-and Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of Two Doses of XXXX in Acutely Psychotic Patients with Schizophrenia.
Clementon; CRI Worldwide
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Clementon; CNS Research Institute
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Clementon; Study Site
Clinical Study of Schizophrenia.
Kenilworth; Study Site
Clinical Study of Schizophrenia.
Nutley; Comprehensive NeuroScience, Inc. Nutley
Passaic, NJ - Schizophrenia
Nutley; Comprehensive NeuroScience, Inc. Nutley
Passaic, NJ - Schizophrenia
New Mexico
Albuquerque; New Mexico VA Health Care System
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
New York
Brooklyn; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Brooklyn; SUNY Downstate Medical Center
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Buffalo; Erie County Medical Center
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Cedarhurst; Neurobehavioral Research, Inc.
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Elmsford; Advanced Bio-Behavioral Sciences
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Holliswood; Comprehensive NeuroScience, Inc. Holliswood
Holliswood, NY - Schizophrenia
Lake Success; Biomedical Research Alliance of New York
Open-Label Study of Aripiprazole in Individuals at Risk for Chronic Mental Illness
Lake Success; Biomedical Research Alliance of New York
Risperidone vs. Sertraline in the Treatment of Attenuated Positive and Negative Symptoms
New York; Mount Sinai Medical Center
Molecular Genetics of Schizophrenia
New York; Mount Sinai Medical Center
Comparison of Atypicals for First Episode (C.A.F.E)
New York; New York State Psychiatric Institute
Schizophrenia Research Studies
New York; Mount Sinai Medical Center
Clinical Antipsychotic Trials of Intervention Effectiveness (C.A.T.I.E)
New York; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
New York; Social Psychiatry Research Institute
Are you suffering from Schizophrenia?
New York; Social Psychiatry Research Institute
Are you suffering from Schizophrenia?
New York; Mount Sinai Medical Center
White Matter Abnormalities in Schizophrenia
New York; New York State Psychiatric Institute
Treatment of Negative Symptoms and Social Dysfunction of Schizophrenia with Transcranial Magnetic Stimulation (TMS)
Olean; Global Research and Consulting
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Orangeburg; Study Site
Clinical Study of Schizophrenia.
Rochester; Strong Ties
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Staten Island; Behavioral Medical Research of Staten Island
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Staten Island; Richmond Behavioral Associates
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
North Carolina
Charlotte; Study Site
Clinical Study of Schizophrenia.
Raleigh; Study Site
Clinical Study of Schizophrenia.
Ohio
Beachwood; Study Site
Clinical Study of Schizophrenia.
Cincinnati; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Cleveland; Saroj Brar, MD, Inc.
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Dayton; Midwest Clinical Research Center
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Oklahoma
Oklahoma City; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Pennsylvania
East Stroudsburg; Bridge Interdisciplinary Research, Inc.
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Norristown; Keystone Clinical Studies, LLC
SCHIZOPHRENIA STUDY
Tennessee
Memphis; CNS Healthcare - Memphis
Schizophrenia Research Study (and Schizoaffective Disorder)
Texas
Austin; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Austin; Study Site
Clinical Study of Schizophrenia.
Bellaire; Study Site
Clinical Study of Schizophrenia.
De Soto; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
DeSoto; InSite Clinical Research
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
DeSoto; Study Site
Clinical Study of Schizophrenia.
Houston; MedLabs Research of Houston, Inc.
Cognitive Deficits in Schizophrenia
Houston; MedLabs Research of Houston, Inc.
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Houston; Medlabs Research of Houston, Inc
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Houston; MedLabs Research of Houston, Inc.
Patients Needed for Schizophrenia Research
Houston; MedLabs Research of Houston, Inc.
If you've been diagnosed with schizophrenia and have been stable for the past five months, that's very good news.
Irving; University Hills Clinical Research
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Virginia
Arlington; Comprehensive NeuroScience, Inc. Arlington
Arlington, VA - Schizophrenia
Richmond; International Clinical Research Associates
International Clinical Research Associates is conducting clinical trials in the following therapeutic areas:
Washington
Tacoma; Charles River Clinical Services Northwest
Healthy Adults CRL#: 08008
Washington, DC
Washington; Comprehensive NeuroScience, Inc. Washington, DC
Washington, DC - Schizophrenia
Wisconsin
Milwaukee; Study Site
Clinical Study of Schizophrenia.
International
Wien, Austria; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Pelotas, Brazil; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Rio De Janeiro, Brazil; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Salvador, Brazil; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Montreal, QUEBEC, Canada; Institut Allan Memorial
Clinical study of investigational agent for patients who have predominantly Negative symptoms of schizophrenia.
Marseille, France; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Orvault, France; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Toulon, France; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Achim, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Bochum, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Freiburg, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Hamburg, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Nürnberg, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Westerstede, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Balassagyarmat, Hungary; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Budapest, Hungary; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Gyor, Hungary; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Nyíregyháza, Hungary; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Aichi, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Chiba, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Fukuoka, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Hiroshima, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Hokkaido, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Nagasaki, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Niigata, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Osaka, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Tokushima, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Tokyo, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Mexico City, Mexico; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Monterrey, Mexico; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Bydgoszcz, Poland; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Skorzewo, Poland; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Torun, Poland; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Tuszyn, Poland; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
